Saito H - Search Results

1

Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori.

Saito Y, Konno K, Sato M, Nakano M, Kato Y, Saito H, Serizawa H. Saito Y, et al. Among authors: saito h. Cancers (Basel). 2019 Jan 19;11(1):116. doi: 10.3390/cancers11010116. Cancers (Basel). 2019. PMID: 30669474 Free PMC article.

2

First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype.

Saito Y, Serizawa H, Kato Y, Nakano M, Nakamura M, Saito H, Suzuki H, Kanai T. Saito Y, et al. Among authors: saito h. World J Gastroenterol. 2015 Dec 28;21(48):13548-54. doi: 10.3748/wjg.v21.i48.13548. World J Gastroenterol. 2015. PMID: 26730167 Free PMC article. Clinical Trial.

3

Role of CTCF in the regulation of microRNA expression.

Saito Y, Saito H. Saito Y, et al. Among authors: saito h. Front Genet. 2012 Sep 25;3:186. doi: 10.3389/fgene.2012.00186. eCollection 2012. Front Genet. 2012. PMID: 23056006 Free PMC article.

4

MicroRNAs in cancers and neurodegenerative disorders.

Saito Y, Saito H. Saito Y, et al. Among authors: saito h. Front Genet. 2012 Sep 26;3:194. doi: 10.3389/fgene.2012.00194. eCollection 2012. Front Genet. 2012. PMID: 23056009 Free PMC article.

5

Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.

Saito Y, Suzuki H, Tsugawa H, Imaeda H, Matsuzaki J, Hirata K, Hosoe N, Nakamura M, Mukai M, Saito H, Hibi T. Saito Y, et al. Among authors: saito h. PLoS One. 2012;7(11):e47396. doi: 10.1371/journal.pone.0047396. Epub 2012 Nov 28. PLoS One. 2012. PMID: 23209550 Free PMC article.

6

Glucose Depletion Enhances the Stem Cell Phenotype and Gemcitabine Resistance of Cholangiocarcinoma Organoids through AKT Phosphorylation and Reactive Oxygen Species.

Yoshikawa N, Saito Y, Manabe H, Nakaoka T, Uchida R, Furukawa R, Muramatsu T, Sugiyama Y, Kimura M, Saito H. Yoshikawa N, et al. Among authors: saito h, saito y. Cancers (Basel). 2019 Dec 11;11(12):1993. doi: 10.3390/cancers11121993. Cancers (Basel). 2019. PMID: 31835877 Free PMC article.

7

Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma.

Nakaoka T, Saito Y, Saito H. Nakaoka T, et al. Among authors: saito h, saito y. Int J Mol Sci. 2017 May 23;18(6):1111. doi: 10.3390/ijms18061111. Int J Mol Sci. 2017. PMID: 28545228 Free PMC article. Review.

8

Establishment and Long-Term Culture of Organoids Derived from Human Biliary Tract Carcinoma.

Saito Y, Muramatsu T, Saito H. Saito Y, et al. Among authors: saito h. STAR Protoc. 2020 Jun 3;1(1):100009. doi: 10.1016/j.xpro.2019.100009. eCollection 2020 Jun 19. STAR Protoc. 2020. PMID: 33111070 Free PMC article.

9

Alterations of epigenetics and microRNA in hepatocellular carcinoma.

Saito Y, Hibino S, Saito H. Saito Y, et al. Among authors: saito h. Hepatol Res. 2014 Jan;44(1):31-42. doi: 10.1111/hepr.12147. Epub 2013 May 26. Hepatol Res. 2014. PMID: 23617364

10

Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review.

Saito Y, Saito H, Liang G, Friedman JM. Saito Y, et al. Among authors: saito h. Clin Rev Allergy Immunol. 2014 Oct;47(2):128-35. doi: 10.1007/s12016-013-8401-z. Clin Rev Allergy Immunol. 2014. PMID: 24362548 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,499 results

Search Page